FDA Approved: VALSARTAN — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved a supplemental application for valsartan from Alembic Pharmaceuticals Limited (ANDA 091367).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension
• Myocardial Infarction

Drugs mentioned

• VALSARTAN (Valsartan)

Snippet

SUPPL AP for VALSARTAN (VALSARTAN)